Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study

Journal of Human Hypertension

Volumn 21, Issue 10, 2007, Pages 795-801

  Ferrara, L A ^a   Cardoni, O ^b   Mancini, M ^a   Zanchetti, A ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Ospedale di Gubbio   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; BODY SIZE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; HYPERTENSION; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

CHI-SQUARE DISTRIBUTION; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ITALY; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

EID: 34548819919     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002232     Document Type: Article

References (29)

1. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 2: 1011-1053.
2. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
3. Alberti KG, Zimmet P, Shaw J; IDF epidemiology task force consensus group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
4. Laurezi M, Cirillo M, Angeletti M, Buongiorno A, Morisi G, Panarelli W et al. Gubbio Population Study: Baseline findings. Nutr Met Cardiovasc Dis 1991; 1: S1-S18.
5. Laurenzi M, Trevisan M. Sodium-lithium countertransport and blood pressure: The Gubbio Population Study. Hypertension 1989; 13 408-415.
6. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
7. Sahn DJ, De Maria A, Kisslo J, Weyman A. The Committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
8. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
9. Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A. Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. Am J Hypertens 2005; 18: 1282-1287.
10. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, De Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260.
11. Ferrara LA, Vaccaro O, Cardoni O, Panarelli W, Laurenzi M, Zanchetti A. Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results from the Gubbio Study. Nutr Met Cardiovac Dis 2003; 13: 126-132.
12. Kuo LC, Quinones MA, Rokey R, Sartori M, Abinader EG, Zoghbi WA. Quantification of atrial contribution to left ventricular filling by pulsed Doppler echocardiography and the effect of age in normal and diseased hearts. Am J Cardiol 1987; 59: 1174-1178.
13. Executive Summary. The third report of the National Cholesterol Educatiuon Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III). JAMA 2001; 285: 2486-2497.
14. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al., American Heart Association; National Heart, Lung and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
16. Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension.. Hypertension 2004; 44: 847-852.
17. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM et al. Obesity, regional body fat distribution and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165: 777-783.
18. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114 345-352.
19. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
20. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 2001; 103 2-7.
21. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: Sex-related differences in the Framingham Heart Study. Circulation 2003; 107: 448-454.
22. Cuspidi C, Meani S, Fusi V, Severgaini B, Valerio C, Catini E et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 1991-1998.
23. Guida L, Celentano A, Iannuzzi R, Ferrara LA. Insulin resistance, ventricular mass and function in normoglycaemic hypertensives. Nutr Metab Cardiovasc Dis 2001; 11: 306-311.
24. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004; 93: 40-44.
25. Ferrara LA, Guida L, Ferrara F, De Luca G, Staiano L, Celentano A et al. Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome. J Hum Hypertens 2007; [E-pub ahead of print: Doi:10.1038/sj.jhh.1002222].
26. Burchfiel CM, Skelton TN, Andrew ME, Garrison RJ, Arnett DK, Jones DW et al. Metabolic syndrome and echocardiographic left ventricular mass in blacks: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2005; 112: 819-827.
27. Devereux RB, Casale PN, Wallerson DC, Kligfield P, Hammond IW, Liebson PR et al. Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension 1987; 9 Part 2): 69-76.
28. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zarrchetti A, et al., On behalf of the APROS investigators. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: The Assessment of Prognostic Risk Observational Survey. J Hypertens 2002; 20: 1307-1314.
29. Bella JN, Polmieri V, Roman MJ, Liu JE, Welty TK, Lee ET et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults. The, Strong Heart Study. Circulation 2002; 105: 1928-1933.